Top Markets
Coin of the day
Novonesis (Novozymes) B Novonesis (Novozymes) B

Novonesis (Novozymes) B

NSISBC
Clasificación en acciones #1197
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Precio por acción
$72.44
Última sincronización: 2026-08-24
Capitalización bursátil
$20.13B
Cambio (1 día)
1.25%
Cambio (1 año)
17.60%
País
DK
Comercio Novonesis (Novozymes) B (NSISBC)
Ganancias de Novonesis (Novozymes) B (NSISBC)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Novonesis (Novozymes) B, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Novonesis (Novozymes) B desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$9.38B -
GB
- -
FR
$3.49B -
US
$2.63B -
US
$-82.10M -
US